If a drug makes someone feel unwell, reduced consumption of food or alcohol may reflect aversion rather than true changes in reward processing
While the legal framework is designed to curb evergreening, litigation tactics can still delay generic entry as even relatively weak secondary patents can temporarily block competition through interim injunctions, experts said
This product is not a drug, food, cosmetic, or dietary supplement and has not been reviewed or approved by the FDA
EzzatvarYRamrez-VlezRIzquierdoMGarcia-HermosoA
1:2500, Abcam, Cambridge, UK), Drp-1 (1:2000, Novus Biotechnology, Littleton, CO, USA), Opa-1 (1:2000, Novus Biotechnology, Littleton, CO, USA), LC3A/B (1:2000, Cell Signaling Technology, Danvers, MA, USA), Tom-20 (1:2000, Santa Cruz Biotechnology, Dallas, TX, USA) and MnSOD (1:2000, Millipore, Billerica, MA, USA), Pink-1 (1:1000, BioVision Incorporated, Milpitas, CA, USA), Fis-1 (1:500, Santa Cruz Biotechnology, Dallas, TX, USA) and Parkin (1:500, Cell Signaling Technology, Danvers, MA, USA) for overnight